Connected polymeric drug delivery systems: A promise for the future!

Thomas Chandy

Article ID: 2901
Vol 6, Issue 1, 2023

VIEWS - 1312 (Abstract) 658 (PDF)

Abstract


Subcutaneous (SC) drug delivery is one of the best routes of drug administration to patients over intravenous (IV) administration due to the ease of application and patient acceptance. The main limitation of using the SC route is administering larger volumes of drug, greater than 3–5 mL for therapeutic dosages. Wearable injectors on body devices are an attractive option for larger-volume drug delivery to patients. Thus, the need for a self-administration strategy at home is growing faster and is required for the next level of time-dependent and high-volume drug delivery. The advances in low-cost, connected on-body delivery systems hold great opportunity for novel ways of delivering home-based drug therapy in the future.


Keywords


SC drug delivery; wearable injectors; remote patient monitoring; connected drug delivery device; home healthcare

Full Text:

PDF


References


1. Fazal T, Murtaza BN, Shah M, et al. Recent developments in natural biopolymer-based drug delivery systems. RSC Advances 2023; 13(33): 23087–23121. doi: 10.1039/d3ra03369d

2. Amjadi M, Sheykhansari S, Nelson BJ, Sitti M. Recent Advances in Wearable Transdermal Delivery Systems. Advanced Materials 2018; 30(7). doi: 10.1002/adma.201704530

3. Chandy T. Biocompatibility of materials and its relevance to drug delivery and tissue engineering. In: Biointegration of Medical Implant Materials. Elsevier; 2020. pp. 297–331. doi: 10.1016/b978-0-08-102680-9.00012-3

4. Chandy T, Rao GHR, Wilson RF, Das GS. Development of Poly (Lactic Acid)/Chitosan Co-Matrix Microspheres: Controlled Release of Taxol-Heparin for Preventing Restenosis. Drug Delivery 2001; 8(2): 77–86. doi: 10.1080/107175401750177025

5. Chandy T, Das GS, Wilson RF, Rao GHR. Development of polylactide microspheres for protein encapsulation and delivery. Journal of Applied Polymer Science 2002; 86(5): 1285–1295. doi: 10.1002/app.11139

6. Simpson I, Bhandari V. Considering the Sustainability Impact of Connected Inhalers in the Treatment of Asthma. ONdrugDelivery; 2022. pp. 42–48.

7. Simpson I. How Connectivity Adds Value to Injectable Drug Delivery Devices. ONdrugDelivery; 2019. pp. 60–64.




DOI: https://doi.org/10.24294/jpse.v6i1.2901

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Thomas Chandy

License URL: https://creativecommons.org/licenses/by-nc/4.0/

This site is licensed under a Creative Commons Attribution 4.0 International License.